Global Multiomics Market
Report Scope:This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.
Report Includes:51 data tables and 55 additional tables
An analysis of the current and future global markets for multiomics
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies’ market shares, recent M&A activity, and venture funding.
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.
Companies MentionedAgilent Technologies Inc.
Beckman Coulter Inc. (Subsidiary Of Danaher Corp.)
Bio-rad Laboratories Inc.
Bd
Bruker
Bgi
F. Hoffmann-la Roche Ltd.
Illumina Inc.
Qiagen
Revvity
Standard Biotools
Thermo Fisher Scientific Inc.